MyNeo

Ottergemsesteenweg Zuid 808 B511

9000 Gent

BE

MyNeo

Foundation date

01/12/2018

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

MyNEO is a Ghent-based biotech company that identifies, validates and explores therapeutic applications of personalized cancer vaccines starting from the patients tumor-specific mutations. The ImmunoEngine bioinformatic platform reports the personalized neoantigens of a patient sample, and is integrated within our end-to-end solution including state-of-the-art sequencing methods, in-vitro immunogenicity tests, and personalized mRNA vaccine construct production.

Upcoming events

Latest news

  • Estetrol recognized as a "New Active Substance" by the European Medicines Agency (EMA)

    12 hours ago

  • Selvita to acquire Fidelta from Galapagos

    1 day ago

  • Qarad opent nieuw kantoor in VK

    1 day ago